Study identifies iron dysregulation in the spleen as a driver of immune aging

Researchers at the Technion – Israel Institute of Technology Faculty of Biology have identified a unique mechanism involved in the aging of the immune system – along with a framework for enhancing its function in older individuals. The study, published in Nature Aging, was led by Assistant Professor Noga Ron-Harel and doctoral student David Ezuz.

The human immune system weakens with age, partly because T cells – white blood cells responsible for identifying and destroying viruses and cancer cells – gradually lose their effectiveness.

The Technion researchers discovered that a key factor in this process is the aging of the spleen, a vital organ in the immune system. In addition to serving as the body's main reservoir of white blood cells, the spleen contains a specialized region responsible for breaking down defective red blood cells and recycling their iron-rich components. This essential process becomes less efficient with age, leading to the accumulation of iron deposits and toxic by-products in the spleen. These create an oxidative environment that damages T cells. The researchers found that even brief exposure of young T cells to an "aged spleen" impairs their immune effectiveness.

In response to this toxic environment, and in an effort to protect themselves, T cells reduce their iron uptake and sequester the iron already present within the cell in protein complexes that lower its availability. However, this protective mechanism has a downside: since available iron is essential for T-cell activation, their ability to respond is significantly weakened.

The researchers went beyond these findings and proposed a way to counter the decline in immune function – controlled iron supplementation at the time of T-cell activation. In experiments on elderly mice, this intervention improved the activation of aged T cells and enhanced the immune response of older mice to vaccination.

The research was supported by the European Research Council (ERC) under the Horizon 2020 program.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
The promise and pitfalls of longevity clinics